Provide pharmaceuticals for Unmet Medical Needs
We will continue to provide life-changing value to as many patients as possible by researching and developing groundbreaking new drugs and marketing them globally.
Initiatives
Evolution in medical treatment
We will strengthen the drug discovery foundation in each research area within our four main modalities, and continue to develop new products.
We will contribute to reducing healthcare spending through the increased use of inexpensive, high quality biomedicines.
Topics
Developing unique pharmaceuticals to bring relief to patients around the world
In accordance with its CSV Commitment in the field of health and well-being, the Kirin Group is working to continuously create ground-breaking new drugs and promote advancements in medical treatments. In line with that commitment, Kyowa Kirin has set the goal of marketing at least three new independently developed pharmaceutical products in over 50 countries.
Improving quality of life of patients around the world
The corporate philosophy of Kyowa Kirin, which conducts the Kirin Group’s medical business, is to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies. Under this philosophy, we are focusing research and development efforts on the four key areas of nephrology, oncology, immunology/allergy, and the central nervous system leveraging our cutting-edge biotechnology anchored in antibody technology.